What is the long-term trend for Zymeworks's accrued progress collections and price adjustments?

Over 4 years (2021 to 2025), Zymeworks's accrued progress collections and price adjustments has grown at a -18.4% compound annual growth rate (CAGR), from $32.94M to $14.61M.

Zymeworks ZYME Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Nurix Therapeutics, Inc.NRIX

——

Septerna, Inc.SEPN

——

Charles River LaboratoriesCRL

——

Adaptive BiotechnologiesADPT

——

BioCryst PharmaceuticalsBCRX

——

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's accrued progress collections and price adjustments?: Zymeworks (ZYME) reported accrued progress collections and price adjustments of $14.61M in Q1 2026.
How has Zymeworks's accrued progress collections and price adjustments changed year-over-year?: Zymeworks's accrued progress collections and price adjustments decreased by 0.0% year-over-year, from $14.61M to $14.61M.
What is the long-term trend for Zymeworks's accrued progress collections and price adjustments?: Over 4 years (2021 to 2025), Zymeworks's accrued progress collections and price adjustments has grown at a -18.4% compound annual growth rate (CAGR), from $32.94M to $14.61M.